Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

"Compassionate use" for public health.

Feemster KA, Offit P.

Ann Intern Med. 2014 Mar 18;160(6):421-2. doi: 10.7326/M13-2927. No abstract available.

PMID:
24366602
2.

Princeton University can import vaccine to combat meningitis outbreak.

[No authors listed]

Clin Infect Dis. 2014 Feb;58(3):i. No abstract available.

3.

Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease.

Rosenqvist E, Holst J, Nøkleby H.

Vaccine. 2007 Jan 22;25(6):965-6. Epub 2006 Oct 4. No abstract available.

PMID:
17052822
4.

Neisseria meningitidis B vaccines.

Panatto D, Amicizia D, Lai PL, Gasparini R.

Expert Rev Vaccines. 2011 Sep;10(9):1337-51. doi: 10.1586/erv.11.103. Review.

PMID:
21919622
5.

[Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].

du Châtelet IP, Alonso JM, Taha MK.

Bull Soc Pathol Exot. 2002 Dec;95(5):323-4; discussion 324-5. Review. French.

PMID:
12696368
6.

In brief: prevention of meningococcus B disease.

[No authors listed]

Med Lett Drugs Ther. 2013 Dec 9;55(1431):97. No abstract available.

PMID:
24322662
7.

Quadrivalent meningococcal conjugate vaccines.

Pace D, Pollard AJ, Messonier NE.

Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Review.

PMID:
19477560
8.

Challenges and progress in the development of a serogroup B meningococcal vaccine.

Lewis S, Sadarangani M, Hoe JC, Pollard AJ.

Expert Rev Vaccines. 2009 Jun;8(6):729-45. doi: 10.1586/erv.09.30. Review.

PMID:
19485754
9.

Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.

Vogel G.

Science. 2003 Mar 7;299(5612):1499-501. No abstract available.

PMID:
12624241
10.

Meningococcal vaccine use in college students.

Kelleher JA, Raebel MA.

Ann Pharmacother. 2002 Nov;36(11):1776-84. Review.

PMID:
12398576
11.

Controlling serogroup B invasive meningococcal disease: the Canadian perspective.

Bettinger JA, Deeks SL, Halperin SA, Tsang R, Scheifele DW.

Expert Rev Vaccines. 2013 May;12(5):505-17. doi: 10.1586/erv.13.30. Review.

PMID:
23659299
12.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
13.

Infectious disease. An ill wind, bringing meningitis.

Roberts L.

Science. 2008 Jun 27;320(5884):1710-5. doi: 10.1126/science.320.5884.1710. No abstract available.

PMID:
18583588
14.

Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, Quinn K, King L, Schmink SE, Wang X, Mayer LW, Clark TA, Gaskell JR, Messonnier NE, DiOrio M, Cohn AC.

Clin Infect Dis. 2013 Aug;57(3):344-8. doi: 10.1093/cid/cit243. Epub 2013 Apr 17.

15.

Towards an improved serogroup B Neisseria meningitidis vaccine.

Perrett KP, Pollard AJ.

Expert Opin Biol Ther. 2005 Dec;5(12):1611-25. Review.

PMID:
16318425
17.
18.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
19.

A case of meningococcal disease in a schoolgirl previously given meningococcal C vaccine.

Pugh RN, Heseltine A.

Commun Dis Public Health. 2002 Mar;5(1):74. No abstract available.

PMID:
12070983
20.

Meningococcal serogroup B infections: a search for a broadly protective vaccine.

Vermont CL, van den Dobbelsteen GP.

Expert Rev Vaccines. 2003 Oct;2(5):673-81. Review.

PMID:
14711328
Items per page

Supplemental Content

Write to the Help Desk